Terms: = Prostate cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
640 results:
1. Concentration of trace elements in blood of Polish patients with prostate cancer.
Drozdz-Afelt JM; Koim-Puchowska B; Kaminski P
Environ Toxicol Pharmacol; 2024 Apr; 107():104425. PubMed ID: 38552756
[TBL] [Abstract] [Full Text] [Related]
2. Expression of stem cell markers as predictors of therapeutic response in metastatic prostate cancer patients.
Nandagopal S; Choudhary G; Sankanagoudar S; Banerjee M; Elhence P; Jena R; Selvi MK; Shukla KK
Urol Oncol; 2024 Mar; 42(3):68.e21-68.e31. PubMed ID: 38278632
[TBL] [Abstract] [Full Text] [Related]
3. Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with cancer.
Chang H; Marquez J; Chen BK; Kim DM; Cheng ML; Liu EV; Yang H; Zhang L; Sinha M; Cheung A; Kwek SS; Chow ED; Bridge M; Aggarwal RR; Friedlander TW; Small EJ; Anderson M; Fong L
Cancer Immunol Res; 2024 Apr; 12(4):453-461. PubMed ID: 38276989
[TBL] [Abstract] [Full Text] [Related]
4. Blood Pb levels are associated with prostate cancer prevalence among general adult males: Linking National cancer Registry (2002-2017) and KNHANES (2008-2017) databases of Korea.
Nam Y; Park S; Kim E; Lee I; Park YJ; Kim TY; Kim MJ; Moon S; Shin S; Kim H; Choi K
Int J Hyg Environ Health; 2024 Mar; 256():114318. PubMed ID: 38171267
[TBL] [Abstract] [Full Text] [Related]
5. Evidence of direct interaction between cisplatin and the caspase-cleaved prostate apoptosis response-4 tumor suppressor.
Raut KK; Pandey S; Kharel G; Pascal SM
Protein Sci; 2024 Mar; 33(3):e4867. PubMed ID: 38093605
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of immune checkpoint inhibitors for patients with prostate cancer: a systematic review and meta-analysis.
Noori M; Azizi S; Mahjoubfar A; Abbasi Varaki F; Fayyaz F; Mousavian AH; Bashash D; Kardoust Parizi M; Kasaeian A
Front Immunol; 2023; 14():1181051. PubMed ID: 38022569
[TBL] [Abstract] [Full Text] [Related]
7. A novel tumor purity and immune infiltration-related model for predicting distant metastasis-free survival in prostate cancer.
Su Q; Zhu Y; He B; Dai B; Mu W; Tian J
Eur J Med Res; 2023 Nov; 28(1):545. PubMed ID: 38017548
[TBL] [Abstract] [Full Text] [Related]
8. M2pep-Modified Cyclodextrin-siRNA Nanoparticles Modulate the Immunosuppressive Tumor Microenvironment for prostate cancer Therapy.
Sun Y; Cronin MF; Mendonça MCP; Guo J; O'Driscoll CM
Mol Pharm; 2023 Nov; 20(11):5921-5936. PubMed ID: 37874541
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive analysis of integrin αvβ3/α6β1 in prognosis and immune escape of prostate cancer.
Liu Y; He JX; Ji B; Wang JF; Zhang L; Pang ZQ; Wang JS; Ding BC; Ren MH
Aging (Albany NY); 2023 Oct; 15(20):11369-11388. PubMed ID: 37862114
[TBL] [Abstract] [Full Text] [Related]
10. Exposure of environmental trace elements in prostate cancer patients: A multiple metal analysis.
Tyagi B; Chandrasekaran B; Tyagi A; Shukla V; Saran U; Tyagi N; Talluri S; Juneau AD; Fu H; Ankem MK; Damodaran C
Toxicol Appl Pharmacol; 2023 Nov; 479():116728. PubMed ID: 37858873
[TBL] [Abstract] [Full Text] [Related]
11. Skills transfer from the DaVinci® system to the Hugo™ RAS system.
Olsen RG; Karas V; Bjerrum F; Konge L; Stroomberg HV; Dagnæs-Hansen JA; Røder A
Int Urol Nephrol; 2024 Feb; 56(2):389-397. PubMed ID: 37773578
[TBL] [Abstract] [Full Text] [Related]
12. The Prognosis-Predictive and Immunoregulatory Role of SUMOylation Related Genes: Potential Novel Targets in prostate cancer Treatment.
Sun JX; An Y; Xiang JC; Xu JZ; Hu J; Wang SG; Xia QD
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686409
[TBL] [Abstract] [Full Text] [Related]
13. Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis.
Cheng W; Liao Y; Mou R; Xiao X; Jia Y
Front Immunol; 2023; 14():1157313. PubMed ID: 37409117
[TBL] [Abstract] [Full Text] [Related]
14. Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity.
Ferraro G; Sanfilippo V; Chiaverini L; Satriano C; Marzo T; Merlino A; La Mendola D
Dalton Trans; 2023 Jul; 52(26):9058-9067. PubMed ID: 37337706
[TBL] [Abstract] [Full Text] [Related]
15. Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1.
Mukherjee D; Romano E; Walshaw R; Zeef LAH; Banyard A; Kitcatt SJ; Cheadle EJ; Tuomela K; Pendharkar S; Al-Deka A; Salerno B; Raby S; Mills IG; Honeychurch J; Illidge TM
Oncoimmunology; 2023; 12(1):2223094. PubMed ID: 37332616
[TBL] [Abstract] [Full Text] [Related]
16. Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI
Nezir AE; Bolat ZB; Ozturk N; Kocak P; Zemheri E; Gulyuz S; Ozkose UU; Yilmaz O; Vural I; Bozkır A; Sahin F; Telci D
Amino Acids; 2023 Aug; 55(8):1023-1037. PubMed ID: 37318626
[TBL] [Abstract] [Full Text] [Related]
17. Association between inflammatory bowel disease and risk of incident prostate cancer: a systematic review and meta-analysis of cohort studies.
Zhou BG; Yu Q; Jiang X; Mei YZ; Ding YB; Wang M
Int J Colorectal Dis; 2023 Jun; 38(1):168. PubMed ID: 37310514
[TBL] [Abstract] [Full Text] [Related]
18. Structural and Biological Features of G-Quadruplex Aptamers as Promising Inhibitors of the STAT3 Signaling Pathway.
Esposito V; Benigno D; Bello I; Panza E; Bucci M; Virgilio A; Galeone A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298475
[TBL] [Abstract] [Full Text] [Related]
19. CYP1A1 gene polymorphism and heavy metal analyses in benign prostatic hyperplasia and prostate cancer: An explorative case-control study.
Singh V; Madeshiya AK; Ansari NG; Singh MK; Abhishek A
Urol Oncol; 2023 Aug; 41(8):355.e9-355.e17. PubMed ID: 37277283
[TBL] [Abstract] [Full Text] [Related]
20. prostate-Specific Membrane Antigen (PSMA) Expression in The Neovasculature of High Grade Gliomas (Histopathological and Immunohistochemical Study).
Abdel Maguid MS; Saad El Dine MG; Gabal SM; Abou Fandoud SM
Asian Pac J Cancer Prev; 2023 May; 24(5):1797-1808. PubMed ID: 37247303
[TBL] [Abstract] [Full Text] [Related]
[Next]
